SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (137)3/11/2004 4:29:39 AM
From: Icebrg  Read Replies (1) | Respond to of 295
 
A truly binary even that we may look forward to during the second half of the year is the presentation of the results from CTIC's Xyotax NSCLC trial(s).

Thanks to its merger with Novuspharma and the granted patent for Trisenox the company is not as exposed to Xyotax as it used to be. But most of the interest surrounding the company has been focused on Xyotax. Whatever the results will be in the trials the share price will move strongly.

Erik